COPD, Respiratory Virus Vaccines, Preeclampsia, and Cardiomyopathy

TT HealthWatch - Sept. 11, 2026
Elizabeth Tracey and Dr. Richard Lange

This week's topics include a new agent for COPD, a roundup of respiratory virus vaccines, a protein that may predict preeclampsia, and treatment for an increasingly recognized cardiac condition.

Program notes:

0:33 Vaccines for RSV, flu, and Covid

1:35 Studies available right now

2:33 Reduction of hospital encounters for infants

3:33 Maternal vaccination for RSV

4:34 Gene silencing therapy for cardiomyopathy

5:35 Decreased primary outcome about 20%

6:35 Should we be screening?

7:06 A new protein to pinpoint preeclampsia

8:05 Low levels in first trimester

9:08 Anchors embryo to uterus

10:05 A new therapy for COPD exacerbations

11:05 Phase three trial of monoclonal

12:34 End

Next
Next

PE, Afib, cognitive function, EKG and syncope